IKNA - Wutah bathi EPS kuartalan Ikena Oncology

Ikena Oncology Inc. (IKNA) - logo korporat

Therapeutic deficits in oncology niches are creating a temporary revenue gap, yet the quarterly EPS comparison clearly demonstrates profit dynamics. The 80.10 mark serves as a key metric for assessing margins. The potential of Ikena Oncology, Inc. (IKNA) is based on targeted developments for hospitals, while the benchmark scalability of innovative molecules guarantees high profitability following drug approval in the precision medicine segment.

Ikena Oncology (IKNA) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan saka 04.07.2022 nganti 09.08.2025

Rincian analitis perusahaan Ikena Oncology, Inc.

- nilai pasar lan prakiraan target analis:
Ringkesan analisis perusahaan:Ikena - IKNA
Barang unggulan ikenaoncology.com

For Ikena Oncology, Inc. (IKNA), a leader in developing targeted therapies for precision oncology, earnings per share dynamics reflect the commercialization efficiency of biomarker research. An analysis of the quarterly EPS growth rate allows for an assessment of the speed of capital recovery and the discipline of expense management, where a steady upward trend confirms the business's internal resilience and minimizes the risks of a sudden investment drawdown.

Analisis pesaing

ONC: Wutah bathi EPS kuartalan|Halozyme Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|RVMD (Revolution Medicines Inc) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Ascentage Pharma Group AAPG|Wutah bathi EPS kuartalan CGON|Wutah bathi EPS kuartalan UroGen Pharma Ltd (URGN)|Wutah bathi EPS kuartalan BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Erasca Oncology - Wutah bathi EPS kuartalan|DCTH: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|YMAB: Wutah bathi EPS kuartalan|Aura Bio (AURA) - Wutah bathi EPS kuartalan|CADL (Candel Therapeutics Inc.) - Wutah bathi EPS kuartalan|ARAY: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan SLS (SELLAS Life Sciences Group, Inc.)|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ACTU|Citius Oncology - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan HURA|TARA: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Fate Pharma|Aadi Bioscience Inc (WHWK) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan TScan (TCRX)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CSBR|xbiotech.com (XBIT) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cel-sci.com (CVM)|OSTX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Radiopharm Theranostics - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ARTV|ANL - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|VERU - Wutah bathi EPS kuartalan|Tempest Therapeutics, Inc. (TPST) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|XLO: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|RENB (Renovaro Biosciences) - Wutah bathi EPS kuartalan|MURA: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan KAPA (Kairos Pharma Ltd)|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan OKUR|CytoMed Therapeutics Limited - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|CRIS: Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|APLM - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|THAR - Wutah bathi EPS kuartalan|ADVB: Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SBFM|Wutah bathi EPS kuartalan XBIO|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Salarius Pharmaceuticals SLRX|Wutah bathi EPS kuartalan PPBT (Purple Biotech Ltd)|AONC - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|BGNE: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Checkpoint Therapeutics, Inc CKPT|ELEV: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan iCAD Inc. (ICAD)|NTBL (Notable Labs Ltd) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Viracta Therapeutics (VIRX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan AAPGV (Ascentage)